SEC Comment Letter 0000000000-23-001035 to Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc.
Date: Feb. 1, 2023 · CIK: 0001707502 · Accession: 0000000000-23-001035
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-269424
Letter
United States securities and exchange commission logo February 1, 2023 Alexander Cumbo Chief Executive Officer Solid Biosciences Inc. 500 Rutherford Avenue Charlestown, MA 02129 Re:Solid Biosciences Inc. Registration Statement on Form S-3 Filed January 26, 2023 File No. 333-269424 Dear Alexander Cumbo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Caroline Dotolo, Esq.
Show Raw Text
United States securities and exchange commission logo
February 1, 2023
Alexander Cumbo
Chief Executive Officer
Solid Biosciences Inc.
500 Rutherford Avenue
Charlestown, MA 02129
Re:Solid Biosciences Inc.
Registration Statement on Form S-3
Filed January 26, 2023
File No. 333-269424
Dear Alexander Cumbo:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at (202) 551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Caroline Dotolo, Esq.